NAACCR talks are webinars on topics of interest to the NAACCR Community presented by members of the NAACCR Community. Topics include cancer surveillance, central registry operations, new technology, upcoming changes, and much more! Registration is free, but you must login using your MyNAACCR username and password. 

Live NAACCR Talks

There are no products which match your search criteria.

On-Demand NAACCR Talks

  • Recorded On: 12/10/2024

    Join us for a special roundtable discussion on the NAACCR Mentorship Program's newest offering: Mentorship Cohorts. These small, facilitator-led groups provide a unique, interactive space for growth, learning, and mutual support. Each cohort fosters an environment of active participation, allowing members to guide and inspire each other along their career paths.

    During this roundtable, we'll cover:

    • Objectives of Mentorship Cohorts
    • Proposed Cohort Structures
    • Guidelines for Participation
    • Small Group Discussion Opportunities

  • Recorded On: 08/26/2024

    This instructional webinar will cover the NAACCR Call for Data process and will highlight critical changes for this year, including new data items and the required tumor-level de-duplication protocol.

    This webinar will be  available for review on the Call for Data Page.

     Call for Data Timeline 2024:

    • Aug 26th CFD Instructional Webinar
    • Sept 1st CFD Resources available on the NAACCR Call for Data Webpage: https://www.naaccr.org/call-for-data/
    • First week of Sept: Match*Pro ver 2.5 release
    • First week of Oct: NAACCR*Prep release (also File*Pro)
    • Nov 1st CFD Portal Opens
    • Dec 3rd NAACCR CFD Due

     If you have any questions, please reach out Recinda Sherman, Program Manager of Data Use and Research. 

    Recinda Sherman, MPH, PhD, CTR

    Program Manager of Data Use and Research

    NAACCR

    Dr. Sherman Program Manager of Data Use & Research, NAACCR received her PhD from University of Miami Miller Medical School and her MPH from Oregon Health & Sciences University. Prior to her role at NAACCR, she worked at the Oregon and Florida registries. 

    Will Howe, BS

    Senior Programmer/Analyst

    Information Management Services

    Mr. Howe is a Senior Programmer/Analyst at Information Management Services, Inc. (IMS) and the creator of Match*Pro.  He has over 10 years of experience in conducting record linkages and studying record linkage concepts/theory.

    Jim Hofferkamp

    Program Manager of Education and Training

    NAACCR

    Jim is the NAACCR Program Manager of Education and Training and NAACCR Edits Metafile Administrator

    Don Green. BS

    Senior Systems Analyst

    Information Management Services

    Mr. Green has over 30 years of experience with IMS, providing biomedical computing support to the National Cancer Institute. Currently, Mr. Green is the manager that oversees the development of the VPR-CLS web portal and the VPR linkage tool Match*Pro. Mr. Green also manages a group of computer programmers supporting NAACCR products including the CINA publication and CiNA*Explorer. Mr. Green is also the task leader for the NCI's Joinpoint software and has worked as a senior systems analyst for NCI's SEER*Stat, TNM and Collaborative staging.

  • Recorded On: 03/26/2024

    During our March roundtable, we'll review the latest updates to the Death Clearance Manual. Additionally, various registries will showcase their Death Clearance procedures, which may include utilizing Web Plus for followback and leveraging Health Information Exchange Data.


    Bobbi Matt

    Manager

    Iowa Cancer Registry

    Bobbi (Mott) has worked for the Iowa Cancer Registry for 27 years.  She is the manager of Data Quality Assurance staff for the Iowa central registry as well as oversee the education and training at the registry.    Bobbi received her RHIT in 1994, ODS in 2000 and Masters in Epidemiology in 2020.  She has done Death Clearance in Iowa for over 25 years.  Throughout the years she has been involved in various workgroups/committees like the NAACCR Death Clearance, MPH, Hematopoietic/Lymphoma, Change Control Board for SEER*DMS and NAACCR Data Consolidation workgroup.  

    Lucinda Ham, RHIA, ODS

    QA and Operations Manager

    Missouri Cancer Registry and Research Center

    Lucinda Ham, RHIA, ODS-C,  joined MCR in 2021, as Quality Assurance Manager. She graduated from Stephens College in 1991 with a bachelor’s in Health Information Management.   Lucinda has 32 years of experience in Health Information Management in the hospital setting which included Cancer Registry. Lucinda has been a ODS-C since 2004. Lucinda is an active member of NCRA.

    Stephanie Phipps, BS, ODS

    Data Collection and Production Supervisor

    Cancer Registry of Greater California

    Stephanie Phipps is the Data Collection and Production Supervisor with The Cancer Registry of Greater California.  Ms. Phipps achieved her CTR in 2008 and has 18 years of service in the cancer registry field.  She has extensive cross-training in many registry functions, managed multiple projects, and has provided training to both new and seasoned registry staff.  

    Vijay Medithi, MBBS, DEM, ODS

    Program Director

    Myriddian, LLC

    Vijay Medithi, MBBS, DEM, CTR, is currently serving as Program Director at Myriddian, LLC where he leads the Maryland Cancer Registry, overseeing all aspects of its operations. Vijay holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree, which he earned from Christian Medical College in India. After practicing clinical medicine in his home country, he relocated to the United States, where he pursued a master’s in public health. Later, he earned a Diploma in Emergency Medicine (DEM). Vijay’s career in disease registry started with Birth Defects Registry and later transitioned to Cancer Registry, at which time he earned the Certified Tumor Registrar (CTR) credential. Vijay’s expertise extends to over 15 years of experience working with both central registries and hospital-based registries. Throughout his career, he has demonstrated a deep understanding of data collection methodologies, analysis techniques, and the importance of data in patient care. His dedication to continuous improvement processes led to the implementation of innovative processes and technologies within the field of cancer registry, enabling improved data management and analysis. He takes pride in his role in enhancing cancer surveillance efforts, ultimately leading to improved patient care and outcomes.

  • Recorded On: 02/26/2024

    Adolescent and Young Adult (AYA) Oncology: The insights gained from the Malignant Germ Cell International Consortium (MaGIC).

    Dr. A. Lindsay Frazier, MD

    One of the most common adolescent and young adult (AYA) cancers are the cell tumors (GCTs), however no significant change has happened to GCTs treatments protocols in the last decades. The Malignant Germ Cell International Consortium (MaGIC) brings together the world’s leading experts in germ cell tumors (GCTs), from across the spectrum of cancer research, with the shared goal of developing more effective treatments for GCTs through scientific inquiry. As the lead of the Malignant Germ Cell Tumor International Consortium, Dr Lindsay will discuss AYA Oncology and share important lessons learned in the field of GCT research.

     

    Forecasting for Accurate Procurement of Pediatric Chemotherapies.

    Dr. Shrivastava, MD, MPH

    Forecasting the cost and quantities of pediatric chemotherapies is an essential part of ensuring a reliable supply of essential medicines for the care of children with cancer. Dr. Shrivastava will describe the importance of access to accurate registry data and its relevance today amongst several critical drug shortages. 

    Dr. A Lindsay Frazier, MD, ScM

    Professor of Pediatrics

    Harvard Medical School

    Dr. Frazier received her MD from Dartmouth Medical School in 1984, followed by a pediatric residency at Children’s Hospital Boston and a pediatric hematology-oncology fellowship at DFCI, where she joined the faculty in 1990. She received an ScM from Harvard School of Public Health in 1993. In clinical practice, she concentrates on germ cell tumors, while her epidemiologic research primarily focuses on colorectal cancer screening and prevention.

    Dr. Nitin Shrivastava, MD, MPH

    Pediatric Hematology /Oncology Fellow

    Dana-Farber/Bostin Children's Cancer and Blood Disorders Center

    Dr. Nitin Shrivastava is a pediatric hematology-oncology fellow in his final year of training at Dana-Farber Cancer Institute/Boston Children’s Hospital. He received his medical degree from the University of Massachusetts Medical School and completed a Master of Public Health at the Harvard T.H. Chan School of Public Health. He completed his residency in general pediatrics at Boston Children’s Hospital. In addition to his clinical work, Nitin has been focused on improving access to pediatric cancer care globally. During his fellowship, he has worked to improve forecasting the amounts and costs of chemotherapy forecasting for pediatric patients in the U.S., Canada, and internationally under the mentorship of Dr. Lindsay Frazier.

  • Recorded On: 01/29/2024

    Next-Gen Cancer Registry: Using AI to Automate Cancer Registry Operations 

    Dr. Jonathan Simkin, Scientific Director BC Cancer Registry

    Dr. Lovedeep Gondara, Research Scientist, Provincial Health Services Authority

    This talk examines the practical implications of artificial intelligence (AI) on cancer registries, focusing on the BC Cancer Registry. Beginning with an analysis of early rule-based approaches in Natural Language Processing (NLP) for cancer coding, we assess both the advantages and limitations of this methodology in the real-world setting. The presentation then explores the impact of these tools on cancer coding and operational efficiency in registries. This talk also demonstrates the BC Cancer Registry's NLP pipelines, presenting their performance metrics across diverse tasks, including case finding from pathology reports and autocoding capabilities that streamline the extraction of critical registry data fields. Finally, this talk will provide insights into how AI-driven automation expedites data processing and strategically addresses resource challenges, offering a pragmatic solution for cancer registry operations. 

    Practical Applications of Natural Language Processing and Machine Learning to Improve Efficiencies and Enhance Central Cancer Registries 

    Dr. Eric Durbin, Director, Kentucky Cancer Registry

    This presentation will cover several examples of efforts in natural language processing and machine learning that are designed to improve efficiencies in registry operations and enhance registry data with content automatically derived from clinical and other documents. 

    ChatGPT, Where Would I Start? 

    Dr. Francis Boscoe, Pumphandle, LLC

    This talk is an introduction to ChatGPT and similar generative AI tools. It will cover the basics of what these tools are, how we might use them, and some of the limitations.

    Jonathan Simkin, PhD, MPH

    Scientific Director

    British Columbia Cancer Registry, BC Cancer, Provincial Health Services Authority

    Dr. Jonathan Simkin, PhD MPH, Scientific Director of the BC Cancer Registry and Co-Chair of the Canadian Council of Cancer Registries, holds a PhD and MPH from the University of British Columbia. His research expertise spans geospatial methods in cancer surveillance, population oncology research, and the application of deep learning methods in cancer surveillance. Dr. Simkin has a ten-year tenure in cancer registry and surveillance settings, including roles as a Cancer Epidemiologist at the Yukon Government and more recently as the Scientific Director of the British BC Cancer Registry at BC Cancer, which he has led since 2019. Dr. Simkin's leadership in implementing cutting-edge technology at the BC Cancer Registry is driving transformative change in cancer data management, ensuring improved efficiency, timeliness, and data quality to support cancer care and research. 

    Lovedeep Gondara, PhD, MS

    Reasearch Scientist

    Provincial Health Services Authority

    Dr. Gondara is a Research Scientist, with specialization in machine learning and biostatistics at the Provincial Health Services Authority (PHSA). His research focus encompasses several areas within machine learning and biostatistics, including natural language processing, multimodal learning, privacy-preserving machine learning, flexible survival regression models, Bayesian statistics, and their integration into the healthcare domain. In his previous role as a biostatistician, Dr. Gondara was responsible for the design and analysis of multiple clinical trials spanning multiple disease domains, such as breast cancer, brain and CNS tumors, cervical cancer screening, etc.

    Eric B Durbin, DrPH, MS

    Director

    Kentucky Cancer Registry

    Eric B. Durbin, DrPH, MS, is an Assistant Professor in the Division of Biomedical Informatics at the University of Kentucky (UK) College of Medicine.  He serves as the Director of the Kentucky Cancer Registry (KCR) and the Director of the Cancer Research Informatics Shared Resource Facility at the UK Markey Cancer Center.  He has over 30 years of experience in population-based cancer surveillance and informatics support for basic, clinical and translational cancer research.  His research interests include precision cancer surveillance, pathology informatics, machine learning methods and cancer epidemiology.
     
    Dr. Durbin’s current research is focused on the integration of multi–omics data to support decision-making in precision medicine and cancer prevention and control, informatics methods to support pediatric and young adult cancer patient surveillance and research and the development of machine learning methods to derive clinical biomarkers from narrative electronic pathology reports and digital slide images.

    Francis P Boscoe, PhD

    Founder

    Pumphandle

    Frank Boscoe worked at the New York State Department of Health from 1999 to 2019, nearly all of that time with the New York State Cancer Registry, before starting his own consulting business in 2019.